Related Experiment Videos

Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol

Archives Internationales De Pharmacodynamie Et De Therapie
|September 1, 1985
PubMed

Insights

Propranolol

Area of Science:

  • Neuropharmacology
  • Cholinergic system research

Background:

  • Oxotremorine-induced tremor (Oxo-tremor) is a model for studying tremor.
  • The role of beta-adrenergic receptors in tremor is not fully understood.

Purpose of the Study:

  • To investigate the effects of propranolol, a beta-adrenergic antagonist, on Oxo-tremor in mice.
  • To explore the interaction between propranolol, atropine, and the cholinergic system in modulating tremor.

Main Methods:

  • Administration of varying doses of propranolol, atropine, timolol, sotalol, and practolol to mice.
  • Induction of tremor using oxotremorine.
  • Measurement of tremor severity.
  • Assessment of cholinesterase activity in mouse brains.

Main Results:

  • Low-dose propranolol antagonized Oxo-tremor, while high doses facilitated it.
  • Atropine blocked Oxo-tremor, an effect reversed by propranolol.
  • Propranolol inhibited cholinesterase at doses that enhanced Oxo-tremor.
  • Timolol and sotalol antagonized Oxo-tremor; practolol did not.

Conclusions:

  • Propranolol exhibits dual effects on Oxo-tremor, suggesting both peripheral and central mechanisms.
  • Peripheral mechanisms may be involved in propranolol's antagonism of tremor.
  • Central cholinergic pathways are implicated in propranolol's facilitation of tremor.

Related Concept Videos